Norovirus News and Research RSS Feed - Norovirus News and Research

Norovirus (formerly Norwalk agent) is an RNA virus (taxonomic family Caliciviridae) that causes approximately 90% of epidemic nonbacterial outbreaks of gastroenteritis around the world, and may be responsible for 50% of all foodborne outbreaks of gastroenteritis in the United States.
New guidelines on how to use social media to communicate effectively about food safety

New guidelines on how to use social media to communicate effectively about food safety

To help protect public health, researchers from North Carolina State University have developed guidelines on how to use social media to communicate effectively about food safety. [More]
Norovirus vaccines: an interview with Dr Benjamin Lopman, Centers for Disease Control and Prevention, USA

Norovirus vaccines: an interview with Dr Benjamin Lopman, Centers for Disease Control and Prevention, USA

Noroviruses are a group of viruses. They're the leading cause of gastroenteritis, which causes diarrhea and vomiting. They affect the whole age range from young children to the elderly, and, in the US, they cause about 20 million cases annually. [More]
Expert guidance offers recommendations for hand hygiene in healthcare facilities

Expert guidance offers recommendations for hand hygiene in healthcare facilities

Expert guidance released today offers updated evidence reviews and recommendations for hand hygiene in healthcare facilities. [More]
Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Wheaton Franciscan Healthcare-Iowa is the latest to deploy TRU-D SmartUVC, a 5-foot-5 germ-killing ultraviolet robot equipped with the only infection prevention data collection and reporting software on the market. TRU-D is now in use at Covenant Medical Center in Waterloo and Sartori Medical Center in Cedar Falls, Iowa. [More]
New estimates highlight the importance of developing norovirus vaccines

New estimates highlight the importance of developing norovirus vaccines

Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors. [More]
Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors. [More]
Salmonella cases are not associated with Danish broiler meat, shows report

Salmonella cases are not associated with Danish broiler meat, shows report

The number of Danes who contracted a salmonella infection reached a historic low level in 2013. More than half of those infected became ill during a trip abroad. [More]
TeleTracking’s hand hygiene technology redefines infection prevention standards at New Cross Hospital

TeleTracking’s hand hygiene technology redefines infection prevention standards at New Cross Hospital

New Cross Hospital, part of The Royal Wolverhampton NHS Trust, today announced a milestone of one million hand hygiene observations using TeleTracking Technologies, Inc.'s automated hand hygiene sensor as part of the 'Safe Hands' program. [More]
Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

Luminex Corporation today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIES™. [More]
Spring Bank announces 3 presentations on SB 9200 at 27th ICAR

Spring Bank announces 3 presentations on SB 9200 at 27th ICAR

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced three presentations on SB 9200, its lead drug candidate for the treatment of Hepatitis B (HBV) and Hepatitis C (HCV) infections, at the 27th International Conference on Antiviral Research (ICAR) being held May 12-16, 2014 at the Raleigh Convention Center in Raleigh, NC. [More]
New report provides in-depth analysis and forecast of global market for HAI products

New report provides in-depth analysis and forecast of global market for HAI products

Reportbuyer.com has added a new market research report: Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products. [More]

FSA project to map occurrence of norovirus in food premises

The University of Liverpool is leading a -2 million Food Standards Agency (FSA) project to map the occurrence of norovirus in food premises and industry workers. [More]
Nearly 179 million cases of acute diarrhea occur each year in the U.S.

Nearly 179 million cases of acute diarrhea occur each year in the U.S.

In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston concluded in a New England Journal of Medicine review article. [More]
Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the first quarter of 2013. Net loss in the first quarter of 2014 was $(9.3) million, or $(0.13) per share, which compares to net income of $0.3 million, or $0.00 per share, in the first quarter of 2013. [More]
Daylight Medical releases SKY 6Xi disinfection technology for mobile devices

Daylight Medical releases SKY 6Xi disinfection technology for mobile devices

Daylight Medical, manufacturer and provider of innovative medical products, is pleased to announce its rollout of SKY 6Xi, disinfection technology for mobile devices. SKY 6Xi uses high intensity (254 nanometer wavelength) ultraviolet light in the "C" spectrum (UVC) at close proximity to thoroughly disinfect a mobile device. The unique power of SKY reduces the risk that Hospital-acquired infections (HAIs) are transmitted to patients while improving safety for healthcare workers. [More]
Frail elderly people are at increased risk of death from outbreaks of viral gastroenteritis

Frail elderly people are at increased risk of death from outbreaks of viral gastroenteritis

Frail elderly people living in residential care facilities are at increased risk of severe illness or death from outbreaks of viral gastroenteritis. [More]
Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Mathematicians at the University of York have joined forces with experimentalists at the University of Leeds to take an important step in discovering how viruses make new copies of themselves during an infection. [More]
New high-speed test to identify contamination of drinking water

New high-speed test to identify contamination of drinking water

Every year 300.000 Europeans are falling ill because of contaminated drinking water. A new high-speed test is being developed to identify the contamination of drinking water much faster than today and thus reduce the number of victims considerably. [More]
Frost & Sullivan: Healthcare acquired infections drive hand hygiene market in Western Europe

Frost & Sullivan: Healthcare acquired infections drive hand hygiene market in Western Europe

The need to prevent and control healthcare acquired infections (HCAI) across Europe, which results in 4.5 to 5 million cases annually, is driving the hand hygiene market in Western Europe. Outbreaks of norovirus and bird flu over the past five years have also served to highlight the importance of hand hygiene in containing infectious diseases. Hand hygiene product manufacturers should take advantage of these trends by offering a one-stop solution for all disinfection requirements. [More]
Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Pregnant women, infants and young children should avoid raw or unpasteurized milk and milk products and only consume pasteurized products, according to a new policy statement from the American Academy of Pediatrics. [More]